Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
The New England Journal of Medicine|March 13, 2018
A Cluster-Randomized Trial of Blood-Pressure Reduction in Black BarbershopsRonald G Victor, Kathleen Lynch, Ning Li, et al.
BMC Complementary and Alternative Medicine|June 28, 2011
Patient education integrated with acupuncture for relief of cancer-related fatigue randomized controlled feasibility studyMichael F Johnston, Ron D Hays, Saskia K Subramanian, et al.
Science Translational Medicine|December 1, 2012
Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophyElizabeth A Martin, Rita Barresi, Barry J Byrne, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 15, 2014
Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung diseaseElizabeth R Volkmann, Rajeev Saggar, Dinesh Khanna, et al.
Cancer|June 3, 2015
Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancerKaren L Reckamp, Marianna Koczywas, Mihaela C Cristea, et al.
The American Journal of Cardiology|April 13, 2016
Acute Effect of Hookah Smoking on the Human Coronary MicrocirculationMichael D Nelson, Mary Rezk-Hanna, Florian Rader, et al.
ACR Open Rheumatology|December 5, 2020
Racial Disparities in Systemic Sclerosis: Short- and Long-Term Outcomes Among African American Participants of SLS I and IIElizabeth R Volkmann, Virginia Steen, Ning Li, et al.
Archives of Neurology|May 16, 2007
Testosterone treatment in multiple sclerosis: a pilot studyNancy L Sicotte, Barbara S Giesser, Vinita Tandon, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 21, 2019
Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung DiseaseGrace Hyun J Kim, Donald P Tashkin, Pechin Lo, et al.
The Journal of Rheumatology|February 17, 2019
Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and IIElizabeth R Volkmann, Donald P Tashkin, Myung Sim, et al.
Pageof 8